Skip to main content
. Author manuscript; available in PMC: 2016 May 1.
Published in final edited form as: Pediatr Blood Cancer. 2014 Oct 12;62(5):743–750. doi: 10.1002/pbc.25269

Figure 3.

Figure 3

Neutralizing Antibodies to NTX-010: 3A) Neutralizing antibodies to NTX-010 on Part A of the study with each color representing a single patient’s data; 3B) Neutralizing antibodies to NTX-010 on Part B of the study with each color representing a single patient’s data. Patients 14 and 17 received a single dose of NTX-010 whereas patients 15 and 18-22 received 2 doses of NTX-010.